跳至主要内容
临床试验/IRCT20190107042264N5
IRCT20190107042264N5招募中3 期

The effect of melatonin on reducing the frequency and intensity of migraine attacks

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Confirmation of migraine according to the criteria of the International Headache Society
  • Chronic migraine patients who are able to distinguish migraine from non-migraine headaches
  • Patients who do not have primary internal and neurologic complaints, there is no other reason for headache in them
  • Filling the written consent form to participate in the study
  • at least 1 year of migraine history

排除标准

  • Severe and debilitating migraine (to eliminate the therapeutic effects of excessive use of painkillers)
  • Chronic daily headache
  • Taking drugs other than propranolol to prevent attacks or taking sleeping pills
  • Migraine Disability Assessment (MIDAS) Grade 4
  • Treatment-resistant migraine (history of unsuccessful treatment with two or more migraine drug classes)
  • History of abnormal use of painkillers and Medication Overuse Headache
  • Significant psychological disorders (psychological illnesses leading to chronic drug use for at least six months)
  • Pregnancy and breastfeeding
  • Primary medical conditions and surgeries that require medical interventions (including contraindications to beta-blockers)
  • Presence of multiple chronic headaches other than migraine with or without medical treatment, such as tension headache
  • History of melatonin allergy or adverse events
  • Patient's request to withdraw from the study due to drug side effects or other reasons

研究者

相似试验